SignaLife


SignaLife develops non-invasive, continuous optical monitoring solutions for real-time blood pH and blood gas assessment aimed at ICU, NICU and obstetric use. The company combines advanced optical sensors, multi-wavelength photoplethysmography signal analysis and physics-informed machine learning to extract physiological measures from surface optical signals.

Industries

artificial-intelligence
information-technology-dbca
medical-device
software

Nr. of Employees

small (1-50)

SignaLife


Products

Continuous adult blood pH and blood gas monitoring system

A continuous, non-invasive system intended to monitor pH and blood gases in adult ICU patients using optical sensors and AI-based signal interpretation.

Neonatal continuous pH monitoring system

A non-invasive monitoring approach aimed at neonatal patients to support timely interventions and reduce procedural pain and potential long-term impacts.

Fetal oxygenation and pH monitoring for delivery

A non-invasive sensor concept intended to provide fetal oxygen/pH-related information during labor to support decisions such as the need for C-section.


Services

R&D and product development for non-invasive optical monitoring

Research and development of optical sensing hardware and software algorithms for continuous blood pH and blood gas monitoring.

Expertise Areas

  • Non-invasive physiological monitoring
  • Critical care monitoring (ICU)
  • Neonatal intensive care monitoring (NICU)
  • Optical sensor R&D
  • Show More (2)

Key Technologies

  • Multi-wavelength photoplethysmography
  • Advanced optical sensor hardware
  • Physics-based light-tissue modeling
  • Machine learning / AI for signal interpretation
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.